Literature DB >> 12176613

Tacrolimus for treatment of bronchiolitis obliterans syndrome after unilateral and bilateral lung transplantation.

Hans-Gerd Fieguth1, S Krueger, D E Wiedenmann, I Otterbach, T O F Wagner.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 12176613     DOI： 10.1016/s0041-1345(02)03108-1

Source DB:  PubMed          Journal:  Transplant Proc        ISSN： 0041-1345            Impact factor:   1.066


× No keyword cloud information.
  5 in total

1.  Pharmacokinetic study of tacrolimus in cystic fibrosis and non-cystic fibrosis lung transplant patients and design of Bayesian estimators using limited sampling strategies.

Authors:  Franck Saint-Marcoux; Christiane Knoop; Jean Debord; Philippe Thiry; Annick Rousseau; Marc Estenne; Pierre Marquet
Journal:  Clin Pharmacokinet       Date:  2005       Impact factor: 6.447

Review 2.  Bronchiolitis obliterans syndrome: risk factors and therapeutic strategies.

Authors:  Andrew I R Scott; Linda D Sharples; Susan Stewart
Journal:  Drugs       Date:  2005       Impact factor: 9.546

3.  Efficacy of concomitant administration of clarithromycin and acetylcysteine in bronchiolitis obliterans in seventeen sulfur mustard-exposed patients: An open-label study.

Authors:  Mostafa Ghanei; Kamran Abolmaali; Jafar Aslani
Journal:  Curr Ther Res Clin Exp       Date:  2004-11

Review 4.  Tacrolimus: a further update of its use in the management of organ transplantation.

Authors:  Lesley J Scott; Kate McKeage; Susan J Keam; Greg L Plosker
Journal:  Drugs       Date:  2003       Impact factor: 9.546

Review 5.  Management of chronic rejection after lung transplantation.

Authors:  Bahaa Bedair; Ramsey R Hachem
Journal:  J Thorac Dis       Date:  2021-11       Impact factor: 2.895
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.